Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2014 Jul;58(7):3785–3790. doi: 10.1128/AAC.02669-14

IS1R-Mediated Plasticity of IncL/M Plasmids Leads to the Insertion of blaOXA-48 into the Escherichia coli Chromosome

R Beyrouthy a,b,c,d, F Robin a,b,d, J Delmas a,b,d, L Gibold a,b,d, G Dalmasso a,b, F Dabboussi c, M Hamzé c, R Bonnet a,b,d,
PMCID: PMC4068556  PMID: 24752261

Abstract

The OXA-48 carbapenemase is mainly encoded by ∼62-kb IncL/M plasmids. However, chromosome-mediated genes have been observed in Escherichia coli isolates. In this work, we investigated the genetic environment of OXA-48 in members of the family Enterobacteriaceae (n = 22) to understand how the OXA-48-encoding gene is transferred into the E. coli chromosome. The OXA-48-encoding gene was located within intact Tn1999.2 transposons in the ∼62-kb plasmids or within a truncated variant of Tn1999.2 for the OXA-48-encoding genes located in the chromosomes of E. coli bacteria. The analysis of the Tn1999.2 genetic environment revealed an inverted orientation of the transposon in five ∼62-kb plasmids (5/14 [35%]) and in all chromosome inserts (n = 8). The sequencing of pRA35 plasmid showed that this orientation of Tn1999.2 and the acquisition of an IS1R insertion sequence generated a 21.9-kb IS1R-based composite transposon encoding OXA-48 and designated Tn6237. The sequencing of a chromosomal insert encoding OXA-48 also revealed this new transposon in the E. coli chromosome. PCR mapping showed the presence of this element in all strains harboring an OXA-48-encoding chromosomal insert. However, different insertion sites of this transposon were observed in the E. coli chromosome. Overall, these findings indicate a plasticity of the OXA-48 genetic environment mediated by IS1R insertion sequences. The insertion sequences can induce the transfer of the OXA-encoding gene into E. coli chromosomes and thereby promote its persistence and expression at low levels.

INTRODUCTION

Carbapenems are broad-spectrum antibiotics that constitute the last-line therapeutic option available to treat infection caused by multidrug-resistant members of the family Enterobacteriaceae (1). However, owing to the emerging resistance to carbapenems worldwide, the antimicrobial activity of these drugs is no longer guaranteed (2). An underlying mechanism is the acquisition of carbapenem-hydrolyzing β-lactamases encoded by genes located on mobile genetic supports, which facilitate their diffusion among bacteria (3).

The OXA-48 carbapenemase was initially identified from a Klebsiella pneumoniae isolate in Turkey (4). It then spread to various Enterobacteriaceae species especially throughout the southern Mediterranean area and in Europe (4, 5). The OXA-48-encoding genes (blaOXA-48) are mostly found in K. pneumoniae and, to a lesser extent, in Escherichia coli and Enterobacter spp. (5). Their emergence is mediated by the rapid spread of strains containing broad-host-range conjugative IncL/M plasmids (68) harboring blaOXA-48 located within the Tn1999-type composite transposon (6, 911). The plasmid implicated in the diffusion of blaOXA-48 was a widespread 62-kb IncL/M plasmid (6). Derivatives have also been reported (7, 8). However, blaOXA-48 was observed in E. coli chromosomes, including in a strong killer strain (12).

The aim of this work was to investigate the genetic environment of blaOXA-48 in order to understand how this gene is transferred into the E. coli chromosome.

MATERIALS AND METHODS

Bacterial isolates.

Twenty-two Enterobacteriaceae strains with reduced susceptibility or resistance to ertapenem and/or imipenem were used in the study (Table 1). Nineteen strains were recovered from clinical samples of patients hospitalized in Nini Hospital, Tripoli, Lebanon, between January 2008 and December 2012. The other three strains were collected in December 2012 during a study investigating intestinal carriage in healthy children. The strains were identified using the matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry (MS) Vitek microbial identification system (bioMérieux, La Balme, France). Rifampin-resistant E. coli C600 was used for mating-out assays.

TABLE 1.

Phenotypic and genotypic characteristics of OXA-48-producing isolates

Isolate STa (E. coli phylogroup) Clinical sampleb (yr) OXA-48 genetic environment
Transposon PCR resultc
Genetic supportd
parA repA traU
E. coli isolates
    EC37 88 (A) Stoole (2012) Inverted ΔTn1999.2 + Chrom
    EC267 88 (A) Sputum (2012) Inverted ΔTn1999.2 + Chrom
    EC264 227 (A) Urine (2012) Inverted ΔTn1999.2 + Chrom
    EC15 127 (B2) Sputum (2011) Inverted ΔTn1999.2 + Chrom
    EC8 131 (B2) Urine (2012) Inverted ΔTn1999.2 + + + Chrom
    EC254 38 (D) Urine (2012) Inverted ΔTn1999.2 + Chrom
    EC265 38 (D) Pus (2012) Inverted ΔTn1999.2 + Chrom
    EC49 38 (D) Stoole (2012) NTf + Chrom
    EC253 617 (A) Urine (2012) Tn1999.2 + + + 62kb
    EC269 617 (A) Urine (2012) Tn1999.2 + + + 62kb
    EC119 3877 (A) Stoole (2012) Tn1999.2 + + + 62kb
    EC260 1711 (B1) Urine (2012) Tn1999.2 + + + 62kb
K. pneumoniae isolates
    KP78 1157 Blood (2012) Tn1999.2 + + + 62kb
    KP87 1156 Pus (2012) Tn1999 + + + 62kb
    KP34 45 Urine (2011) Tn1999.2 + + + 62kb
    KP9 866 Urine (2009) Inverted Tn1999.2 + + + 62kb
    KP26 866 Urine (2008) Tn1999.2 + + + 62kb
E. aerogenes EA2 Pus (2012) Inverted Tn1999.2 + + + 62kb
E. cloacae isolates
    ECL6 Urine (2010) Inverted Tn1999.2 + + + 62kb
    ECL8 Urine (2009) Tn1999.2 + + + 62kb
C. koseri CK8 Urine (2011) Inverted Tn1999.2 + + + 62kb
R. planticola RA35 Pus (2011) Inverted Tn1999.2 + + + 62kb
a

Sequence types for E. coli and K. pneumoniae isolates.

b

Clinical sample that the strain was isolated from.

c

PCR result for “pOXA-48a genes.”

d

Chrom, chromosome-mediated OXA-48; 62kb, ∼62-kb IncL/M plasmid encoding OXA-48.

e

Fecal carriage in children having no known contact with a hospital.

f

NT, nontypeable Tn1999-type environment.

Determination of genetic relatedness and E. coli phylogroup.

The genetic relatedness of the strains was determined by multilocus sequence typing (MLST). Allelic profiles and sequence types (STs) were assigned using the MLST schema of Diancourt et al. (13) and Wirth et al. (14) for K. pneumoniae and E. coli isolates, respectively.

Molecular characterization of blaOXA-48 and the associated transposon.

The OXA-48-encoding genes were detected by PCR amplification as previously reported (12). The genetic environment of the blaOXA-48 gene was further investigated by PCR and sequencing using specific primers to map the transposon composites Tn1999 to Tn1999.4 (6, 911) (Table 2). The orientation of these transposons in their genetic environments was investigated by PCR and sequencing using combinations of primers targeting blaOXA-48 (5′-AATACACGCATAACGTCCCC-3′ and 5′-GCCATCACAAAAGAAGTGCTC-3′), lysR (5′-GCTGCAAATAGCATCATACC-3′), orf67 (5′-CAGCCAGAATAAGAGCAATC-3′), and pemI (5′-TGACCATGCCAACTTCATT-3′). The sequences of PCR products were established on both strands by dideoxy chain terminator using an Applied Biosystems sequencer.

TABLE 2.

Primers used in this study

Target Primer sequence (5′ to 3′ end) Positioning of primers in pOXA-48a sequence Reference
IS1999 CAGCAATTCTTTCTCCGTG 2.780–2.798/7.520–7502a 6
CAAGCACAACATCAAGCGC 3.764–3.746/6.536–6.554a
blaOXA-48 AATACACGCATAACGTCCCC 6.232–6.251 32
GCCATCACAAAAGAAGTGCTC 5.489–5.469
lysR GCTAGTGCCAATCTTACAGG 4.983–5.002 10
GCTGCAAATAGCATCATACC 4.262–4.243
pemI TGACCATGCCAACTTCATT 8.022–8.004 This study
AAACATACCAGCCTTTAACG 7.869–7.850
CCCTCCTGACCAGCCGCC 8.163–8.149
trbB CACCGCTTCACCAGAAAA 61.698–61.715 This study
trbA GAAGCGTTCCGAGAATTTG 519–501 This study
trbN CAGAGAATTTTGGTAAACC 1.314–1.332 This study
CCGCCCTCAATCCCGCTGC 1.688–1.670
mucA CGTTCACTGTCATGAGACAC 8.995–9.014 This study
GGATCAATACCTTCTCCG 10.203–10.187
parA GCAGTGAAAACGTTGATCAG 18.746–18.765 6
GATCGCAATGCGTCTTGGTG 19.277–19.258
nuc GATAAGAATCTGGAAGAAAC 20.047–20.066 This study
GAGCCTTGATAATACGACG 20.745–20.727
orf22 CCTGCAGGGCTATTTATTC 22.482–22.500 This study
korC TTTTGCGCTGCTATTTCC 23.859–23.842 This study
orf25 GGAAATAGCAGCGCAAAA 23.842–23.859 This study
CCATAACATCGCCATCAT 24.048–24.031
ATGATGGCGATGTTATGG 24.031–24.048
GGTTCGATGCCCGTATTG 25.237–25.220
orf28 GACTGGCGCAGGAGTAAA 28.046–28. 063 This study
orf30 GTGGTTCAGGGTGAACAG 29.678–29.661 This study
mobB TATCTGATGAGCCGTAGC 33.189–33206 This study
mobA CGCTCTTCCATCGACTTC 34.487–34.470 This study
traJ GCACCAGGAAGGTTTGAT 37.849–37.866 This study
CGGGTTCTTTCAGTTGCA 38.251–38.234
traU ATCTCACGCAATCTTACGTC 48.129–48.148 6
TCGCGTCATGCGTGATCTTC 48.705–48.686
repA GACATTGAGTCAGTAGAAGG 56.427–56.446 6
CGTGCAGTTCGTCTTTCGGC 57.351–57.332
a

Positioning of primers corresponding to the two copies of IS1999.

Plasmid analysis.

The transferability of the blaOXA-48 gene was studied by a mating-out assay. Selection was performed on agar plates supplemented with ticarcillin (32 μg/ml) and rifampin (300 μg/ml). The plasmid content of bacteria and the size of plasmids were determined using plasmid DNA extracted by the method of Kado and Liu (15) with the plasmids Rsa (39 kb), TP114 (61 kb), pCFF04 (85 kb), and pCFF14 (180 kb) as standards. Plasmid restriction analysis was performed from DNA extracted by alkaline lysis and digested with EcoRI and HindIII restriction endonucleases (Boehringer Mannheim, Meylan, France). PCR-based replicon typing (PBRT) was used to identify plasmid incompatibility groups in transconjugants (16). The repA, traU, and parA genes were detected by PCR to relate the OXA-48-encoding plasmids to the pOXA-48a IncL/M plasmid as previously described (6).

Chromosome analysis.

The chromosomal location of the blaOXA-48 gene was investigated by pulsed-field gel electrophoresis (PFGE) using the I-CeuI endonuclease and hybridization with probes specific for the 16S rRNA genes, blaOXA-48 gene and IS1999, as previously described (17). The chromosomal insertion of blaOXA-48 was further mapped by PCR using blaOXA-48-containing DNA fragments purified from pulsed-field gels and primers specific for pOXA-48a. Seventeen primer pairs (Table 2) covering pOXA-48a plasmid backbone were used for PCR mapping; the targets were trbN, pemI, mucA, nuc, orf22, orf23, orf24, korC, orf28, orf29, orf30, mobB, mobA, traJ, traU, repA, and parA.

Amplification by nested TAIL-PCR.

The sites flanking the pOXA-48 insertion site in the E. coli chromosome were amplified by a nested thermal asymmetric interlaced PCR (TAIL-PCR) approach. The primer targeting the pOXA-48 insert was ORF-25-R1 (R stands for reverse) (5′-GCCAGCGAGAAGCGAACAAAACG-3′), and the arbitrary degenerate primers were TAIL-pcr-F1 (F stands for forward) (5′-GTAATACGACTCACTATAGGGCACGCGTGGTNTCGASTWTSGWGTT-3′), TAIL-pcr-F2 (5′-GTAATACGACTCACTATAGGGCACGCGTGGTNGTCGASWGANAWGAA-3′), and TAIL-pcr-F3 (5′-GTAATACGACTCACTATAGGGCACGCGTGGTWGTGNAGWANCANAGA-3′). The amplifications comprised 15 standard PCR cycles, including 10 high-stringency cycles (annealing temperature, 62°C) and then 5 low-stringency cycles (annealing temperature, 35°C). The PCR product (1 μl) was then amplified under high-stringency conditions by nested PCR (annealing temperature, 62°C) using the primer ORF25-R2 (5′-CGCAACATCAAAACGAGCTCC-3′) and a primer targeting the adaptor part of the degenerated primers (5′-GTAATACGACTCACTATAGGGC-3′).

Plasmid and chromosome sequencing.

Plasmid DNA of Raoultella planticola strain RA35 was purified with the NucleoBond Xtra Midi kits (Macherey-Nagel) following the manufacturer's instructions. After fragmentation, DNA was sequenced with Roche 454 GS-FLX system. The genomic DNA of E. coli EC15 was extracted and purified using the Gentra Puregene Yeast/Bact kit (Qiagen, Valencia, CA) and sequenced using Illumina sequencing technology with 500-bp paired-end libraries.

Bioinformatic analyses.

The de novo assemblies were performed with MIRA package (mimicking intelligent read assembly implemented in Linux) (18). The contiguous sequences (contigs) were then aligned with the pOXA-48a plasmid sequence (JN626286) using the BLAST algorithm (19). The gaps and insertions between contigs were closed or checked by PCR and Sanger sequencing. Open reading frames (ORFs) were predicted and annotated using RATT (20). The resulting annotation was manually checked and curated using Artemis (21). The resulting DNA sequences were compared with the pOXA-48a sequence using Easyfig (22).

RESULTS

Genetic background of bacteria.

The 22 isolates included in this study produced the carbapenemase OXA-48. The isolates belonged to the E. coli (clinical strains [n = 9]; colonizing strains [n = 3]), K. pneumoniae (n = 5), Enterobacter cloacae (n = 2), Enterobacter aerogenes (n = 1), Raoultella planticola (n = 1), and Citrobacter koseri (n = 1) species. The genetic background of K. pneumoniae and E. coli producing OXA-48 was investigated by MLST (Table 1). Three K. pneumoniae isolates (KP9, KP26, and KP112) belonged to sequence type 866 (ST866). The three other K. pneumoniae isolates were assigned to ST45 (KP34), ST1156 (KP78), and ST1157 (KP87). Seven STs were represented among E. coli isolates (ST227 [n = 2], ST617 [n = 2], ST38 [n = 3], ST88 [n = 2], ST131 [n = 1], ST1711 [n = 1], and ST127 [n = 1]), and they covered all E. coli phylogroups (Table 1).

Location of blaOXA-48 in plasmids or chromosome.

OXA-48-encoding transconjugants were obtained from 14 strains with OXA-48-encoding genes. Plasmids from natural isolates and their transconjugants were extracted and hybridized with a blaOXA-48 probe. The results showed that the blaOXA-48 gene was located on ∼62-kb plasmids (64% [14/22] [Table 1]). Further analysis of these plasmids from transconjugants revealed similar restriction profiles (data not shown). None of the plasmids could be assigned to an incompatibility group by the PBRT method. However, the repA, traU, and parA genes of pOXA-48a were detected in all plasmids, suggesting that the plasmids had an IncL/M pOXA-48a-like backbone.

Despite many attempts, no transconjugants or transformants were obtained from eight unrelated E. coli isolates belonging to the A, D, and B2 E. coli phylogroups. The insertion of blaOXA-48 into the bacterial chromosome was therefore investigated by PFGE after I-CeuI nuclease treatment and hybridization. Distinct DNA fragments, with a range of 600 to 880 kb, hybridized with the blaOXA-48 probe (data not shown), suggesting that the insertion of blaOXA-48 in E. coli chromosomes is not rare (8/22 [36%]) and may occur at different sites.

Genetic environment of blaOXA-48.

The blaOXA-48 gene was identified as part of the transposons designated Tn1999 to Tn1999.4 (6, 911). To characterize the genetic environment of blaOXA-48 in our strains, we mapped by PCR and sequencing the Tn1999-type transposons harboring blaOXA-48. The blaOXA-48 gene was predominantly associated with Tn1999.2 (68% [15/22]). However, the eight blaOXA-48 genes on E. coli chromosomes (32% [7/22]) were located in incomplete Tn1999.2 elements, in which the IS1999 element flanking blaOXA-48 was truncated. Finally, blaOXA-48 was carried by Tn1999 in K. pneumoniae KP87, and we were unable to identify a Tn1999-type element in E. coli EC49.

PCR mapping covering the whole sequence of pOXA-48a was then performed by targeting 17 genes and the sequences overlapping Tn1999.2 edges. The complete backbone of pOXA-48a was observed in all bacteria, except for E. coli harboring a chromosome-mediated OXA-48 gene, in which we observed PCR products only for sequences located between blaOXA-48 and orf25 of pOXA-48a. In addition, no amplification was obtained with the primers targeting the sequences overlapping Tn1999.2 edges for five plasmids and in all E. coli harboring a chromosome-mediated OXA-48 gene, suggesting a significant rearrangement in the vicinity of the transposon encoding OXA-48.

Sequence of pRA35 plasmid.

To investigate the rearrangement of Tn1999.2, we sequenced the ∼62-kb plasmid of R. planticola RA35(pRA35) using a next-generation sequencing approach. The sequencing reactions of pRA35 plasmid yielded 9,607 reads with an average length of 407 bases. A total of 9,303 reads with an average length of 355 bases were conserved (97%) after trimming, amounting to a total number of 3,302,032 bases of DNA. After contig assembling, gap closing, and repeat sequence mapping by Sanger sequencing, a total of 8,576 reads (92% of reads with an average length of 354 bases) totaling 3,037,308 bases were assembled to obtain the complete sequence of pRA35, resulting in an average of 47× sequence coverage (range, 38× to 121×). Overall, the complete sequencing of pRA35 showed an IncL/M circular plasmid of 63.434 kb with an average G+C content of 51.2%. The pRA35 and pOXA-48a nucleotide sequences shared overall 99% identity, and most of the synteny was conserved. Differences in the DNA sequence were observed in several genes or open reading frames; the most divergent genes were the nuclease-encoding gene and the DNA primase gene. However, the pRA35 plasmid differed from the reference plasmid pOXA-48a in three major respects (Fig. 1): (i) the insertion of an additional copy of the IS1R insertion sequence in orf25, (ii) the presence of the Tn1999.2 transposon, which differs from Tn1999 by the insertion of the IS1R insertion sequence in the IS1999 insertion sequence located upstream of blaOXA-48, and (iii) an inverted orientation of Tn1999.2. The orientation of Tn1999.2 was investigated in all OXA-48-encoding plasmids by PCR mapping and sequencing. The inverted orientation was detected in five plasmids (5/14 [35%]).

FIG 1.

FIG 1

Comparison of pRA35 plasmid and blaOXA-48 chromosome-mediated insert (Tn6237) with pOXA-48a plasmid. (A) Schematic diagram showing the rearrangements in Tn1999-type transposons encoding OXA-48. (B) Global comparison performed using the bioinformatics tools Easyfig. The transposases of insertion sequences are represented by red arrows for IS1R and black arrows for IS1999, blaOXA-48 by gray arrows, genes implicated in transfer and mobility (mob and tra) by navy blue arrows, genes specific to pOXA-48a-like plasmids (parA, traU, and parA) by light blue arrows, and E. coli chromosome genes by green arrows.

Sequence of the chromosome insert containing the blaOXA-48 gene.

To understand the insertion of blaOXA-48 into the E. coli chromosome, the blaOXA-48 environment was sequenced in E. coli strain EC15 using a next-generation sequencing approach. The sequencing reactions yielded 18,710,176 reads with an average length of 101 bases. A total of 18,441,693 reads of 93-base average lengths were conserved (98.6%) after trimming. Three contigs containing sequences corresponding to pOXA-48a were obtained by de novo assembling. After gap closing and repeat sequence mapping by Sanger sequencing, we obtained a contiguous sequence of 27.6 kb, which contained a 21.8-kb central fragment related to the pOXA-48a sequence flanked by 2.7-kb and 3.1-kb E. coli chromosome sequences. A total of 112,059 reads (0.6%) with an average length of 93 bases totaling 10,415,879 bases were aligned to 100% of this sequence, resulting in an average of 377× sequence coverage (range, 62× to 795×).

The sequence of the blaOXA-48 chromosomal insert shared 100% identity with the pRA35 sequence and identical synteny (Fig. 1). The insert was flanked by two copies of IS1R, the first provided by the truncated and inverted Tn1999.2 transposon, and the second inserted into orf25, as observed in the pRA35 plasmid. The deletion in Tn1999.2 was due to the loss of residual IS1999 sequences upstream of Tn1999.2-located IS1R. Between the IS1R insertion sequences, after the truncated Tn1999.2 transposon, we observed 9 genes (pemI, pemK, mucA, mucB, resD, parA, parB, nuc, and korC) and 18 hypothetical ORFs, as previously observed in pRA35 and pOXA-48a. These genes and ORFs, associated with the flanking IS1R insertion sequences, formed an IS1R-based composite transposon designated Tn6237. The flanking regions of this element corresponded to the hypothetical gene orf33 belonging to the II536 pathogenicity island, which has been observed in the reference uropathogenic strain E. coli 536 (23). Twelve-base imperfect direct repeats (GATCACTTAGAT and GATCTTTTAGAT) were observed at the site of inversion, suggesting that the insertion of Tn6237 into the E. coli chromosome is the result of a transposition event. PCR mapping of Tn6237 in E. coli showed that Tn6237 is conserved in all strains harboring a chromosome-mediated OXA-48-encoding gene. However, sequencing of nested TAIL-PCR products revealed distinct insertion sites. In the EC264 strain (ST227, phylogroup A), the blaOXA-48 insert was detected in the yqjF gene, which encodes a putative quinol oxidase subunit. In E. coli EC8 (ST131, phylogroup B2), the blaOXA-48 insert was detected in an intergenic region ∼375 bp at the 5′ site of the pgi gene (glucose-6-phosphate isomerase). Overall, these data showed that the chromosome-mediated blaOXA-48 inserts exhibited similar organization in all strains and corresponded to a novel composite transposon, which can be inserted in different sites of the E. coli chromosome.

DISCUSSION

Mobile genetic elements, including large broad-host-range plasmids, transposons, and insertion sequences (IS) have played a part in the evolution and generation of diversity of bacterial populations. They performed a critical role in the horizontal and vertical transfer and rapid spread of virulence factors and drug resistance genes in Enterobacteriaceae. IncL/M-type plasmids are currently detected worldwide in Enterobacteriaceae isolates of different origin and are considered to be epidemic resistance plasmids (24). They were implicated in the large dissemination of specific genes encoding extended-spectrum β-lactamases (ESBL), in particular the blaCTX-M-3 gene. IncL/M-type plasmids have also been reported to contribute to the diffusion of the carbapenemase-encoding genes blaNDM-1 and blaOXA-48.

In this study, most blaOXA-48 genes were also located in ∼62-kb IncL/M plasmids related to pOXA-48a, as previously observed in Europe and the Mediterranean region (25). However, most plasmids harbored blaOXA-48 inserted into the Tn1999.2 transposon and not into the Tn1999 transposon, as previously observed in pOXA-48a. In addition, 67% (8/12) of OXA-48-producing E. coli strains investigated in this study harbored a chromosome-mediated gene encoding OXA-48. The chromosome location of blaOXA-48 is therefore not rare and is observed in unrelated E. coli isolates. This chromosomal location of blaOXA-48 was associated with the presence of a truncated form of Tn1999.2 and significant rearrangement in the vicinity of this element.

To investigate the mechanism underlying the chromosomal location of the OXA-48-encoding gene, we sequenced plasmid pRA35, the chromosomal insert encoding blaOXA-48 in E. coli EC15 and flanking regions of two additional chromosomal inserts. We observed a 21.9-kb blaOXA-48-encoding and composite transposon designated Tn6237 in the E. coli chromosome and pRA35. This element was detected in all strains harboring an OXA-48-encoding chromosomal insert. It forms an IS1R-based composite transposon harboring blaOXA-48, which is responsible for its insertion into the E. coli chromosome.

IS1 is one of the smallest bacterial insertion sequences isolated so far. It is 768 bp long, includes two ∼23-bp imperfect inverted repeats (IRL [inverted repeat left] and IRR [inverted repeat right]) located at its ends, and two partly overlapping open reading frames (insA and insB′) located in the 0 and −1 relative translational phases, respectively (26). IS1 transposition may appear as a simple insertion or as a replicative fusion event (27, 28). The origin of the second copy of IS1R observed in pRA35 and Tn6237 may therefore be the result of the replicative transposition of the IS1R insertion sequence located in Tn1999.2.

The IS1 transposition can occur in both orientations, and the direction of IS1 is not an important factor in transposition. Reports have mentioned that the gene being mobilized should be flanked by short terminal inverted repeats within the IS1 sequence regardless of the orientation of the two IS1 elements (29). The orientation of the IS1R elements in Tn6237 and pRA35 is therefore compatible with the formation of a functional composite transposon. IS1-based composite transposons (elements Tn9 and Tn1681) have already been reported (30). In Tn1681, the mobile element is flanked by two inverted repeats of IS1, which bracket the E. coli heat-stable toxin. In Tn9 and derivatives, a gene encoding chloramphenicol acetyltransferase is bracketed by two direct repeats of the IS1 insertion sequence, as observed in our blaOXA-48-encoding transposon. In the E. coli EC15 chromosome, this IS1R-based transposable element is flanked by direct repeats of the insertion site, which may be marks of a transposition event.

Investigation of the target specificity of the IS1 element indicated that acquisition of IS1 is generally located within or directly adjacent to the A+T-rich content segments (31). The Tn6237 insertion site in the EC15 strain is the orf33 gene of the pathogenicity island (PAI) II536, which has been previously reported in the uropathogenic Escherichia coli 536 strain (23). The orf33 gene (1.668 kb) and surrounding sequence are characterized by a very low-GC percentage (∼33%), as at the insertion sites in E. coli EC264 (∼44%) and EC8 (∼37%). Likewise, the IS1R insertion sites in the orf25 gene in pRA35 and Tn6237 are identical and characterized by a low GC percentage (40%), which makes a putative hot spot of IS1R insertion in the backbone of pOXA-48a-like IncL/M plasmids and therefore a region likely to be variable.

In this work, we provide new insights into the blaOXA-48 genetic environment and describe its high plasticity, which is promoted by Tn1999.2 inversion and IS1R elements responsible for the transposition of the OXA-48-encoding fragment derived from pOXA-48 in E. coli chromosomes.

ACKNOWLEDGMENTS

We thank Laurent Guillouard and Alexis Pontvianne for technical assistance.

This research project was supported by the National Council for Scientific Research, Lebanon and by the AZM Research Center of Biotechnology, Lebanese University, Lebanon, the Ministère de la Recherche et de la Technologie, l'Institut National de la Recherche Agronomique (USC-2018), and the Centre Hospitalier Régional Universitaire de Clermont-Ferrand, France.

We declare that we have no conflicts of interest.

Footnotes

Published ahead of print 21 April 2014

REFERENCES

  • 1.Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657–686. 10.1128/CMR.18.4.657-686.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Nordmann P, Dortet L, Poirel L. 2012. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol. Med. 18:263–272 [DOI] [PubMed] [Google Scholar]
  • 3.Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791–1798 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen Ø, Seifert H, Woodford N, Nordmann P, European Network on Carbapenemases 2012. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 18:413–431. 10.1111/j.1469-0691.2012.03821.x [DOI] [PubMed] [Google Scholar]
  • 5.Poirel L, Potron A, Nordmann P. 2012. OXA-48-like carbapenemases: the phantom menace. J. Antimicrob. Chemother. 67:1597–1606. 10.1093/jac/dks121 [DOI] [PubMed] [Google Scholar]
  • 6.Poirel L, Bonnin RA, Nordmann P. 2012. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob. Agents Chemother. 56:559–562. 10.1128/AAC.05289-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Berger S, Alauzet C, Aissa N, Hénard S, Rabaud C, Bonnet R, Lozniewski A. 2013. Characterization of a new blaOXA-48-carrying plasmid in Enterobacteriaceae. Antimicrob. Agents Chemother. 57:4064–4067. 10.1128/AAC.02550-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Espedido BA, Steen JA, Ziochos H, Grimmond SM, Cooper MA, Gosbell IB, van Hal SJ, Jensen SO. 2013. Whole genome sequence analysis of the first Australian OXA-48-producing outbreak-associated Klebsiella pneumoniae isolates: the resistome and in vivo evolution. PLoS One 8:e59920. 10.1371/journal.pone.0059920 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Carrër A, Poirel L, Yilmaz M, Akan OA, Feriha C, Cuzon G, Matar G, Honderlick P, Nordmann P. 2010. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob. Agents Chemother. 54:1369–1373. 10.1128/AAC.01312-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Giani T, Conte V, Di Pilato V, Aschbacher R, Weber C, Larcher C, Rossolini GM. 2012. Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative. Antimicrob. Agents Chemother. 56:2211–2213. 10.1128/AAC.00035-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Potron A, Nordmann P, Rondinaud E, Jaureguy F, Poirel L. 2013. A mosaic transposon encoding OXA-48 and CTX-M-15: towards pan-resistance. J. Antimicrob. Chemother. 68:476–477. 10.1093/jac/dks397 [DOI] [PubMed] [Google Scholar]
  • 12.Beyrouthy R, Robin F, Cougnoux A, Dalmasso G, Darfeuille-Michaud A, Mallat H, Dabboussi F, Hamzé M, Bonnet R. 2013. Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli. J. Antimicrob. Chemother. 68:1558–1561. 10.1093/jac/dkt051 [DOI] [PubMed] [Google Scholar]
  • 13.Diancourt L, Passet V, Verhoef J, Grimont PAD, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43:4178–4182. 10.1128/JCM.43.8.4178-4182.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MCJ, Ochman H, Achtman M. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60:1136–1151. 10.1111/j.1365-2958.2006.05172.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kado CI, Liu ST. 1981. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145:1365–1373 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219–228. 10.1016/j.mimet.2005.03.018 [DOI] [PubMed] [Google Scholar]
  • 17.Bonnet R, Marchandin H, Chanal C, Sirot D, Labia R, De Champs C, Jumas-Bilak E, Sirot J. 2002. Chromosome-encoded class D beta-lactamase OXA-23 in Proteus mirabilis. Antimicrob. Agents Chemother. 46:2004–2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chevreux B, Wetter T, Suhai S. 1999. Genome sequence assembly using trace signals and additional sequence information. Proceedings of the German Conference on Bioinformatics, GCB ‘99, 4 to 6 October 1999, Hannover, Germany [Google Scholar]
  • 19.Zhang Z, Schwartz S, Wagner L, Miller W. 2000. A greedy algorithm for aligning DNA sequences. J. Comput. Biol. 7:203–214. 10.1089/10665270050081478 [DOI] [PubMed] [Google Scholar]
  • 20.Otto TD, Dillon GP, Degrave WS, Berriman M. 2011. RATT: Rapid Annotation Transfer Tool. Nucleic Acids Res. 39:e57. 10.1093/nar/gkq1268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Carver T, Berriman M, Tivey A, Patel C, Bohme U, Barrell BG, Parkhill J, Rajandream M-A. 2008. Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database. Bioinformatics 24:2672–2676. 10.1093/bioinformatics/btn529 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sullivan MJ, Petty NK, Beatson SA. 2011. Easyfig: a genome comparison visualizer. Bioinformatics 27:1009–1010. 10.1093/bioinformatics/btr039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Brzuszkiewicz E, Brüggemann H, Liesegang H, Emmerth M, Olschläger T, Nagy G, Albermann K, Wagner C, Buchrieser C, Emody L, Gottschalk G, Hacker J, Dobrindt U. 2006. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc. Natl. Acad. Sci. U. S. A. 103:12879–12884. 10.1073/pnas.0603038103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bonnin RA, Nordmann P, Carattoli A, Poirel L. 2013. Comparative genomics of IncL/M-type plasmids: evolution by acquisition of resistance genes and insertion sequences. Antimicrob. Agents Chemother. 57:674–676. 10.1128/AAC.01086-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Potron A, Kalpoe J, Poirel L, Nordmann P. 2011. European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone. Clin. Microbiol. Infect. 17:E24–E26 [DOI] [PubMed] [Google Scholar]
  • 26.Hirsch HJ, Starlinger P, Brachet P. 1972. Two kinds of insertions in bacterial genes. Mol. Gen. Genet. 119:191–206. 10.1007/BF00333858 [DOI] [PubMed] [Google Scholar]
  • 27.Biel SW, Berg DE. 1984. Mechanism of IS1 transposition in E. coli: choice between simple insertion and cointegration. Genetics 108:319–330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Galas DJ, Chandler M. 1982. Structure and stability of Tn9-mediated cointegrates. Evidence for two pathways of transposition. J. Mol. Biol. 154:245–272 [DOI] [PubMed] [Google Scholar]
  • 29.So M, Heffron F, McCarthy BJ. 1979. The E. coli gene encoding heat stable toxin is a bacterial transposon flanked by inverted repeats of IS1. Nature 277:453–456. 10.1038/277453a0 [DOI] [PubMed] [Google Scholar]
  • 30.So M, McCarthy BJ. 1980. Nucleotide sequence of the bacterial transposon Tn1681 encoding a heat-stable (ST) toxin and its identification in enterotoxigenic Escherichia coli strains. Proc. Natl. Acad. Sci. U. S. A. 77:4011–4015. 10.1073/pnas.77.7.4011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zerbib D, Gamas P, Chandler M, Prentki P, Bass S, Galas D. 1985. Specificity of insertion of IS1. J. Mol. Biol. 185:517–524. 10.1016/0022-2836(85)90068-3 [DOI] [PubMed] [Google Scholar]
  • 32.Beyrouthy R, Robin F, Cougnoux A, Dalmasso G, Darfeuille-Michaud A, Mallat H, Dabboussi F, Hamzé M, Bonnet R. 2013. Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli. J. Antimicrob. Chemother. 68:1558–1561. 10.1093/jac/dkt051 [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES